

Learn about Amlodipine/Telmisartan side effects, from common issues like swelling and dizziness to serious warning signs. Know when to call your doctor.
Every medication has potential side effects, and Amlodipine/Telmisartan is no exception. The good news is that most people tolerate this combination blood pressure medication well, and serious side effects are uncommon. But it helps to know what's normal, what's not, and when you should reach out to your doctor.
This guide covers the most common and serious side effects of Amlodipine/Telmisartan based on FDA labeling and clinical data, plus practical tips for managing them.
Amlodipine/Telmisartan is a combination tablet that contains two blood pressure medications in one pill. Amlodipine is a calcium channel blocker (CCB) and Telmisartan is an angiotensin II receptor blocker (ARB). Together, they lower blood pressure through two different mechanisms, which often works better than either drug alone.
It's available as a generic (the brand name Twynsta has been discontinued) in four strengths: 40/5 mg, 40/10 mg, 80/5 mg, and 80/10 mg.
These side effects occur in a noticeable percentage of people taking Amlodipine/Telmisartan. They're usually mild and often improve as your body adjusts to the medication over the first few weeks.
These are less common but require medical attention. Contact your doctor right away — or go to the emergency room — if you experience any of these:
Amlodipine/Telmisartan carries an FDA black box warning for fetal toxicity. Medications that act on the renin-angiotensin system (like Telmisartan) can cause injury and death to the developing fetus. If you become pregnant or are planning to become pregnant, stop taking Amlodipine/Telmisartan and contact your doctor immediately.
It is not recommended to take Amlodipine/Telmisartan while breastfeeding. Talk to your doctor about safer alternatives if you're nursing.
Patients over 65 may be more sensitive to the blood-pressure-lowering effects, increasing the risk of dizziness and falls. Doctors typically start with a lower dose of Amlodipine (5 mg) in elderly patients. Amlodipine/Telmisartan is generally not recommended as initial therapy in patients 75 and older.
If you have liver problems (hepatic impairment) or kidney disease, your doctor may need to adjust your dose or monitor you more closely. Severe hepatic impairment and biliary obstruction are contraindications — meaning you should not take this medication.
If you have diabetes, you should not take Amlodipine/Telmisartan together with Aliskiren (Tekturna), as the combination increases the risk of kidney problems, dangerously high potassium, and low blood pressure.
Most common side effects can be managed without stopping the medication. Here are some practical tips:
If side effects don't improve after 2-4 weeks, or if they're significantly affecting your quality of life, talk to your doctor. Options may include:
Never stop taking Amlodipine/Telmisartan suddenly without talking to your doctor. Stopping abruptly can cause a rebound spike in blood pressure.
Some medications and supplements can increase the risk of side effects when taken with Amlodipine/Telmisartan. For a complete list, read our guide on Amlodipine/Telmisartan drug interactions.
Key ones to be aware of:
Amlodipine/Telmisartan is an effective and generally well-tolerated combination for managing high blood pressure. Most side effects are mild and temporary — swelling, dizziness, and fatigue are the most common complaints. Serious side effects are rare but important to recognize.
The key is open communication with your doctor. Report any new or worsening symptoms, keep up with recommended blood work, and don't adjust your dose on your own. With proper monitoring, most people do well on this medication long-term.
If you're looking for the best price on your prescription, check out how to save money on Amlodipine/Telmisartan or use Medfinder to find it in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.